)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
NeoGenomics (NEO) investor relations material
NeoGenomics Stephens Annual Investment Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Stephens Annual Investment Conference summary19 Nov, 2025
Business performance and growth drivers
Clinical business saw strong growth with 15% volume and 18% revenue increases, offsetting pharma headwinds for 12% overall revenue growth in the quarter.
NGS segment grew 24%, now representing almost a third of the clinical portfolio, driven by volume and new product launches.
Five high-value NGS products now account for 24% of clinical revenue, with ongoing investments in sales specialists to drive further penetration.
Rebranding under the PanTracer family simplified the value proposition, leading to increased adoption and broader market reach.
MRD space re-entry with RaDaR ST is expected to fuel growth, with a formal clinical launch planned for next year.
Product development and portfolio strategy
PanTracer LBx is expected to ramp through 2025, with reimbursement upside possible but not critical to guidance.
Early adoption of PanTracer Tissue and HRD is broad-based, aligning with national cancer incidence trends.
EAP program and product updates improved assay competitiveness, report structure, and turnaround time.
Liquid CGP adoption is driven by actionable results, integration, and reduced workflow friction for community oncologists.
Portfolio focus is on execution with current robust offerings, with opportunistic expansion in proteomics or genome areas.
Commercial and operational initiatives
Desiloing sales model uses data-driven targeting, improving win rates and sales cycle efficiency by 2x.
Pathline (NeoRamsey) integration completed, with a robust pipeline in the Northeast and expected accretive impact by 2026.
Margin improvements expected from NGS volume growth, LIMS integration, automation, pricing, and RCM platform upgrades, with most benefits realized in 2027.
M&A will be selective, focusing on tuck-in or bolt-on deals that fill portfolio gaps.
PanTracer LBx MolDX status and 2025-26 paid volume assumptions
What drives pharma business recovery by 2027?
Key drivers for margin expansion beyond NGS mix
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next NeoGenomics earnings date
Piper Sandler 37th Annual Healthcare Conference2 Dec, 2025
Next NeoGenomics earnings date
Piper Sandler 37th Annual Healthcare Conference2 Dec, 2025
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
NeoGenomics Inc provides cancer-focused genetic testing services, including clinical and research laboratory diagnostics. The company offers molecular, cytogenetic, and flow cytometry testing to pathologists, oncologists, and pharmaceutical companies. It supports precision medicine and oncology drug development. The company is headquartered in Fort Myers, Florida, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage